Heart Failure (Congestive Heart Failure).
Shams P, Malik A, Chhabra L.
2025 Feb 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.
Zannad F, Ferreira JP, Pocock SJ, Anker SD, Butler J, Filippatos G, Brueckmann M, Ofstad AP, Pfarr E, Jamal W, Packer M.
Lancet. 2020 Sep 19;396(10254):819-829. doi: 10.1016/S0140-6736(20)31824-9. Epub 2020 Aug 30.
Clinical Implications of the New York Heart Association Classification.
Caraballo C, Desai NR, Mulder H, Alhanti B, Wilson FP, Fiuzat M, Felker GM, Piña IL, O'Connor CM, Lindenfeld J, Januzzi JL, Cohen LS, Ahmad T.
J Am Heart Assoc. 2019 Dec 3;8(23):e014240. doi: 10.1161/JAHA.119.014240. Epub 2019 Nov 27.
The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
Mortensen SA, Rosenfeldt F, Kumar A, Dolliner P, Filipiak KJ, Pella D, Alehagen U, Steurer G, Littarru GP; Q-SYMBIO Study Investigators.
JACC Heart Fail. 2014 Dec;2(6):641-9. doi: 10.1016/j.jchf.2014.06.008. Epub 2014 Oct 1.
Heart function grading evaluation based on heart sounds and convolutional neural networks.
Chen X, Guo X, Zheng Y, Lv C.
Phys Eng Sci Med. 2023 Mar;46(1):279-288. doi: 10.1007/s13246-023-01216-9. Epub 2023 Jan 10.
Is the Ability index superior to the NYHA classification for assessing heart failure?: comparison of two classification scales in adolescents and adults with operated congenital heart defects.
Norozi K, Wessel A, Buchhorn R, Alpers V, Arnhold JO, Zoege M, Geyer S.
Clin Res Cardiol. 2007 Aug;96(8):542-7. doi: 10.1007/s00392-007-0530-z. Epub 2007 Jun 27.
[Association of plasma amino-terminal pro-A-, B- and C-type natriuretic peptide levels with NYHA grade and echocardiographic derived parameters of cardiac function in heart failure patients].
Zhao XY, Yang YJ, Zhang J, Kang LM, Wei BQ, Gao XJ, Lü R, Zhang CL.
Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Jun;37(6):486-90.
Revisiting heart failure assessment based on objective measures in NYHA functional classes I and II.
Blacher M, Zimerman A, Engster PHB, Grespan E, Polanczyk CA, Rover MM, Neto JAF, Danzmann LC, Bertoldi EG, Simões MV, Beck-da-Silva L, Biolo A, Rohde LE.
Heart. 2021 Sep;107(18):1487-1492. doi: 10.1136/heartjnl-2020-317984. Epub 2020 Dec 23.
Associations Between New York Heart Association Classification, Objective Measures, and Long-term Prognosis in Mild Heart Failure: A Secondary Analysis of the PARADIGM-HF Trial.
Rohde LE, Zimerman A, Vaduganathan M, Claggett BL, Packer M, Desai AS, Zile M, Rouleau J, Swedberg K, Lefkowitz M, Shi V, McMurray JJV, Solomon SD.
JAMA Cardiol. 2023 Feb 1;8(2):150-158. doi: 10.1001/jamacardio.2022.4427.
Acupuncture for heart failure: A systematic review of clinical studies.
Lee H, Kim TH, Leem J.
Int J Cardiol. 2016 Nov 1;222:321-331. doi: 10.1016/j.ijcard.2016.07.195. Epub 2016 Jul 30.
